038: Epigenetic aberrations in chronic lymphocytic leukemia

HIPO Investigator:

Dr. Mertens

Dr. Rippe

Dr. Seiffert


Supported by: HIPO

Entity: CLL


Wolf C. et al.; NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutini; Int J Cancer. 2017

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.